December 15, 2016
NOXXON/Merck to study drugs combination in cancer treatment
NOXXON Pharma N.V. has announced a collaboration with Merck & Co. (MSD), Inc, under which the two companies will collaborate…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
December 15, 2016
Bioven gets green light for NSC cancer drug testing patient enrolment
A cancer-focused drug-maker Bioven can now enrol patients in the USA in its international Phase III trial of EGF-PTI, in…
December 15, 2016
Kiadis Pharma starts a P I/II clinical trial for thalassemia treatment
Kiadis Pharma N.V., a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders…
December 15, 2016
TiGenix raises $35.65M proceeds with NASDAQ IPO
A biopharmaceutical company TiGenix focused on allogeneic expanded stem cells, has raised $35.65 million gross proceeds from the sale of 2,300,000 American Depository…
December 15, 2016
Argenx launches P I/II clinical trial for acute myeloid leukemia treatment
Argenx, a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe…
December 15, 2016
Biocartis CE-marks Idylla NRAS-BRAF Mutation Test
Biocartis has CE-marked its solid biopsy Idylla NRAS-BRAF Mutation Test. On Thursday, Biocartis said that, together with the CE-marked Idylla…
December 15, 2016
PureTech health finishes tolerability testing of KarXT for schizophrenia and Alzheimer’s
Karuna Pharmaceuticals and a subsidiary of PureTech Health have finished studying antipsychotic for schizophrenia and Alzheimer’s disease – KarXT. The…
December 14, 2016
Horizon’s biomanufacturing business boosts revenue
Horizon Discovery Group has provided an update on the commercial operation of its Biomanufacturing business with significant growth in cell…
December 14, 2016
J&J shareholding in Biocartis decreases
Johnson&Johnson has decreased its shareholding in Biocartis, the Belgian drugmaker said on Wednesday. In a disclosure of a transparency notification,…
December 14, 2016
Genticel: two year trial of HPV16/18 immunotherapeutic candidate fails
Genticel, a clinical-stage biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), has…